Oxytocin in the ventromedial hypothalamic nucleus reduces feeding and acutely increases energy expenditure

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 307, Issue 6, 2014, Pages R737-R745

  Noble, Emily E ^a   Billington, Charles J ^a,b,c,d   Kotz, Catherine M ^a,c,d   Wang, Chuan Feng ^a,c,d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c University of Minnesota   (United States)

^d VA MEDICAL CENTER   (United States)

Author keywords

Energy expenditure; Feeding; Obesity; Oxytocin; Ventromedial hypothalamus

Indexed keywords

OXYTOCIN; OXYTOCIN RECEPTOR; ANTIOBESITY AGENT;

ANIMAL EXPERIMENT; ARTICLE; CALORIMETRY; CONDITIONED TASTE AVERSION TEST; CONTROLLED STUDY; DIGESTION; ENERGY EXPENDITURE; FEEDING; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; MALAISE; MALE; NONHUMAN; PHYSICAL ACTIVITY; RAT; SATIETY; ANIMAL; DIET RESTRICTION; DOSE RESPONSE; DRUG EFFECT; EATING; ENERGY METABOLISM; FEEDING BEHAVIOR; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; MOTOR ACTIVITY; OBESITY; PSYCHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME; ZONA INCERTA;

ENERGY EXPENDITURE; FEEDING; OBESITY; OXYTOCIN; VENTROMEDIAL HYPOTHALAMUS;

ANIMALS; ANTI-OBESITY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; ENERGY METABOLISM; FASTING; FEEDING BEHAVIOR; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY; SATIETY RESPONSE; TIME FACTORS; VENTROMEDIAL HYPOTHALAMIC NUCLEUS;

EID: 84907153649     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00118.2014     Document Type: Article

References (65)

1. Amico JA, Vollmer RR, Cai HM, Miedlar JA, Rinaman L. Enhanced initial and sustained intake of sucrose solution in mice with an oxytocin gene deletion. Am J Physiol Regul Integr Comp Physiol 289: R1798–R1806, 2005.
2. Arletti R, Benelli A, Bertolini A. Oxytocin inhibits food and fluid intake in rats. Physiol Behav 48: 825–830, 1990.
3. Baskin DG, Kim F, Gelling RW, Russell BJ, Schwartz MW, Morton GJ, Simhan HN, Moralejo DH, Blevins JE. A new oxytocin-saporin cytotoxin for lesioning oxytocin-receptive neurons in the rat hindbrain. Endocrinology 151: 4207–4213, 2010.
4. Blevins JE, Eakin TJ, Murphy JA, Schwartz MW, Baskin DG. Oxytocin innervation of caudal brainstem nuclei activated by cholecysto-kinin. Brain Res 993: 30–41, 2003.
5. Blevins JE, Ho JM. Role of oxytocin signaling in the regulation of body weight. Rev Endocr Metab Disord 14: 311–329, 2013.
6. Blevins JE, Schwartz MW, Baskin DG. Evidence that paraventricular nucleus oxytocin neurons link hypothalamic leptin action to caudal brain stem nuclei controlling meal size. Am J Physiol Regul Integr Comp Physiol 287: R87–R96, 2004.
7. Blouet C, Jo YH, Li X, Schwartz GJ. Mediobasal hypothalamic leucine sensing regulates food intake through activation of a hypothalamus-brainstem circuit. J Neurosci 29: 8302–8311, 2009.
8. Boccia ML, Petrusz P, Suzuki K, Marson L, Pedersen CA. Immuno-histochemical localization of oxytocin receptors in human brain. Neuro-science 253: 155–164, 2013.
9. Camerino C. Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity (Silver Spring) 17: 980–984, 2009.
10. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev 84: 277–359, 2004.
11. Deblon N, Veyrat-Durebex C, Bourgoin L, Caillon A, Bussier AL, Petrosino S, Piscitelli F, Legros JJ, Geenen V, Foti M, Wahli W, Di Marzo V, Rohner-Jeanrenaud F. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One 6: e25565, 2011.
12. Feldmann HM, Golozoubova V, Cannon B, Nedergaard J. UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab 9: 203–209, 2009.
13. Flak JN, Jankord R, Solomon MB, Krause EG, Herman JP. Opposing effects of chronic stress and weight restriction on cardiovascular, neuroen-docrine and metabolic function. Physiol Behav 104: 228–234, 2011.
14. Gaetani S, Fu J, Cassano T, Dipasquale P, Romano A, Righetti L, Cianci S, Laconca L, Giannini E, Scaccianoce S, Mairesse J, Cuomo V, Piomelli D. The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin. J Neurosci 30: 8096–8101, 2010.
15. Gaetani S, Oveisi F, Piomelli D. Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacol-ogy 28: 1311–1316, 2003.
16. Gavini CK, Mukherjee S, Shukla C, Britton SL, Koch LG, Shi H, Novak CM. Leanness and heightened nonresting energy expenditure: role of skeletal muscle activity thermogenesis. Am J Physiol Endocrinol Metab 306: E635–E647, 2014.
17. Griffin GD, Ferri-Kolwicz SL, Reyes BA, Van Bockstaele EJ, Flana-gan-Cato LM. Ovarian hormone-induced reorganization of oxytocin-labeled dendrites and synapses lateral to the hypothalamic ventromedial nucleus in female rats. J Comp Neurol 518: 4531–4545, 2010.
18. Kasahara Y, Sato K, Takayanagi Y, Mizukami H, Ozawa K, Hidema S, So KH, Kawada T, Inoue N, Ikeda I, Roh SG, Itoi K, Nishimori K. Oxytocin receptor in the hypothalamus is sufficient to rescue normal thermoregulatory function in male oxytocin receptor knockout mice. Endocrinology 154: 4305–4315, 2013.
19. Kasahara Y, Takayanagi Y, Kawada T, Itoi K, Nishimori K. Impaired thermoregulatory ability of oxytocin-deficient mice during cold-exposure. Biosci Biotechnol Biochem 71: 3122–3126, 2007.
20. Kublaoui BM, Gemelli T, Tolson KP, Wang Y, Zinn AR. Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol Endocrinol 22: 1723–1734, 2008.
21. Leng G, Onaka T, Caquineau C, Sabatier N, Tobin VA, Takayanagi Y. Oxytocin and appetite. Prog Brain Res 170: 137–151, 2008.
22. Lokrantz CM, Uvnas-Moberg K, Kaplan JM. Effects of central oxy-tocin administration on intraoral intake of glucose in deprived and non-deprived rats. Physiol Behav 62: 347–352, 1997.
23. Maejima Y, Iwasaki Y, Yamahara Y, Kodaira M, Sedbazar U, Yada T. Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass. Aging 3: 1169–1177, 2011.
24. Maejima Y, Sedbazar U, Suyama S, Kohno D, Onaka T, Takano E, Yoshida N, Koike M, Uchiyama Y, Fujiwara K, Yashiro T, Horvath TL, Dietrich MO, Tanaka S, Dezaki K, Oh IS, Hashimoto K, Shimizu H, Nakata M, Mori M, Yada T. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab 10: 355–365, 2009.
25. Manning M, Misicka A, Olma A, Bankowski K, Stoev S, Chini B, Durroux T, Mouillac B, Corbani M, Guillon G. Oxytocin and vaso-pressin agonists and antagonists as research tools and potential therapeutics. J Neuroendocrinol 24: 609–628, 2012.
26. Morton GJ, Thatcher BS, Reidelberger RD, Ogimoto K, Wolden-Hanson T, Baskin DG, Schwartz MW, Blevins JE. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. Am J Physiol Endocrinol Metab 302: E134–E144, 2012.
27. Mullis K, Kay K, Williams DL. Oxytocin action in the ventral tegmental area affects sucrose intake. Brain Res 1513: 85–91, 2013.
28. Nicholson C. Diffusion from an injected volume of a substance in brain tissue with arbitrary volume fraction and tortuosity. Brain Res 333: 325–329, 1985.
29. Okamatsu-Ogura Y, Nio-Kobayashi J, Iwanaga T, Terao A, Kimura K, Saito M. Possible involvement of uncoupling protein 1 in appetite control by leptin. Exp Biol Med (Maywood) 236: 1274–1281, 2011.
30. Olson BR, Drutarosky MD, Chow MS, Hruby VJ, Stricker EM, Verbalis JG. Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides 12: 113–118, 1991.
31. Olson BR, Drutarosky MD, Stricker EM, Verbalis JG. Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake. Endocrinology 129: 785–791, 1991.
32. Olszewski PK, Fredriksson R, Eriksson JD, Mitra A, Radomska KJ, Gosnell BA, Solvang MN, Levine AS, Schioth HB. Fto colocalizes with a satiety mediator oxytocin in the brain and upregulates oxytocin gene expression. Biochem Biophys Res Commun 408: 422–426, 2011.
33. Olszewski PK, Klockars A, Schioth HB, Levine AS. Oxytocin as feeding inhibitor: maintaining homeostasis in consummatory behavior. Pharmacol Biochem Behav 97: 47–54, 2010.
34. Ott V, Finlayson G, Lehnert H, Heitmann B, Heinrichs M, Born J, Hallschmid M. Oxytocin reduces reward-driven food intake in humans. Diabetes 62: 3418–3425, 2013.
35. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Boston, MA: Elsevier Academic, 2007.
36. Perello M, Raingo J. Leptin activates oxytocin neurons of the hypotha-lamic paraventricular nucleus in both control and diet-induced obese rodents. PLoS One 8: e59625, 2013.
37. Perez-Leighton CE, Boland K, Billington CJ, Kotz CM. High and low activity rats: elevated intrinsic physical activity drives resistance to diet-induced obesity in non-bred rats. Obesity (Silver Spring) 21: 353–360, 2013.
38. Peters JH, McDougall SJ, Kellett DO, Jordan D, Llewellyn-Smith IJ, Andresen MC. Oxytocin enhances cranial visceral afferent synaptic transmission to the solitary tract nucleus. J Neurosci 28: 11731–11740, 2008.
39. Pow DV, Morris JF. Differential distribution of acetylcholinesterase activity among vasopressin- and oxytocin-containing supraoptic magno-cellular neurons. Neuroscience 28: 109–119, 1989.
40. Rinaman L. Oxytocinergic inputs to the nucleus of the solitary tract and dorsal motor nucleus of the vagus in neonatal rats. J Comp Neurol 399: 101–109, 1998.
41. Rodriguez de Fonseca F, Navarro M, Gomez R, Escuredo L, Nava F, Fu J, Murillo-Rodriguez E, Giuffrida A, LoVerme J, Gaetani S, Kathuria S, Gall C, Piomelli D. An anorexic lipid mediator regulated by feeding. Nature 414: 209–212, 2001.
42. Romano A, Cassano T, Tempesta B, Cianci S, Dipasquale P, Coc-curello R, Cuomo V, Gaetani S. The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons. Pep-tides 49: 21–26, 2013.
43. Rosen GJ, de Vries GJ, Goldman SL, Goldman BD, Forger NG. Distribution of oxytocin in the brain of a eusocial rodent. Neuroscience 155: 809–817, 2008.
44. Sabatier N, Leng G, Menzies J. Oxytocin feeding, and satiety. Front Endocrinol (Lausanne) 4: 35, 2013.
45. Sakaguchi T, Arase K, Bray GA. Sympathetic activity and food intake of rats with ventromedial hypothalamic lesions. Int J Obes 12: 285–291, 1988.
46. Sokol HW, Zimmerman EA, Sawyer WH, Robinson AG. The hypo-thalamic-neurohypophysial system of the rat: localization and quantitation of neurophysin by light microscopic immunocytochemistry in normal rats and in Brattleboro rats deficient in vasopressin and a neurophysin. Endocrinology 98: 1176–1188, 1976.
47. Striepens N, Kendrick KM, Maier W, Hurlemann R. Prosocial effects of oxytocin and clinical evidence for its therapeutic potential. Front Neuroendocrinol 32: 426–450, 2011.
48. Swaab DF, Purba JS, Hofman MA. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. J Clin Endocrinol Metab 80: 573–579, 1995.
49. Swanson LW, Kuypers HG. The paraventricular nucleus of the hypo-thalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J Comp Neurol 194: 555–570, 1980.
50. Takahashi A, Ishimaru H, Ikarashi Y, Kishi E, Maruyama Y. Effects of ventromedial hypothalamus stimulation on glycogenolysis in rat liver using in vivo microdialysis. Metab Clin Exp 46: 897–901, 1997.
51. Takayanagi Y, Kasahara Y, Onaka T, Takahashi N, Kawada T, Nishimori K. Oxytocin receptor-deficient mice developed late-onset obesity. Neuroreport 19: 951–955, 2008.
52. Teske JA, Levine AS, Kuskowski M, Levine JA, Kotz CM. Elevated hypothalamic orexin signaling, sensitivity to orexin A, and spontaneous physical activity in obesity-resistant rats. Am J Physiol Regul Integr Comp Physiol 291: R889–R899, 2006.
53. Tribollet E, Dubois-Dauphin M, Dreifuss JJ, Barberis C, Jard S. Oxytocin receptors in the central nervous system. Distribution, development, and species differences. Ann NY Acad Sci 652: 29–38, 1992.
54. Tsujii S, Bray GA. A fj-3 adrenergic agonist (BRL-37,344) decreases food intake. Physiol Behav 63: 723-728, 1998.
55. Tung YC, Ma M, Piper S, Coll A, O’Rahilly S, Yeo GS. Novel leptin-regulated genes revealed by transcriptional profiling of the hypothalamic paraventricular nucleus. J Neurosci 28: 12419-12426, 2008.
56. Uchoa ET, Zahm DS, de Carvalho Borges B, Rorato R, Antunes-Rodrigues J, Elias LL. Oxytocin projections to the nucleus of the solitary tract contribute to the increased meal-related satiety responses in primary adrenal insufficiency. Exp Physiol 98: 1495-1504, 2013.
57. Vander Tuig JG, Knehans AW, Romsos DR. Reduced sympathetic nervous system activity in rats with ventromedial hypothalamic lesions. Life Sci 30: 913-920, 1982.
58. Wang C, Bomberg E, Billington C, Levine A, Kotz CM. Brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus increases energy expenditure by elevating metabolic rate. Am J Physiol Regul Integr Comp Physiol 293: R992-R1002, 2007.
59. Wang C, Bomberg E, Levine A, Billington C, Kotz CM. Brain-derived neurotrophic factor in the ventromedial nucleus of the hypothalamus reduces energy intake. Am J Physiol Regul Integr Comp Physiol 293: R1037-R1045, 2007.
60. Wang C, Kotz CM. Urocortin in the lateral septal area modulates feeding induced by orexin A in the lateral hypothalamus. Am J Physiol Regul Integr Comp Physiol 283: R358-R367, 2002.
61. Wu Z, Xu Y, Zhu Y, Sutton AK, Zhao R, Lowell BB, Olson DP, Tong Q. An obligate role of oxytocin neurons in diet induced energy expenditure. PLoS One 7: e45167, 2012.
62. Yamashita M, Takayanagi Y, Yoshida M, Nishimori K, Kusama M, Onaka T. Involvement of prolactin-releasing peptide in the activation of oxytocin neurones in response to food intake. J Neuroendocrinol 25: 455–465, 2013.
63. Zhang G, Bai H, Zhang H, Dean C, Wu Q, Li J, Guariglia S, Meng Q, Cai D. Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance. Neuron 69: 523-535, 2011.
64. Zhang G, Cai D. Circadian intervention of obesity development via resting-stage feeding manipulation or oxytocin treatment. Am J Physiol Endocrinol Metab 301: E1004-E1012, 2011.
65. Zhang H, Wu C, Chen Q, Chen X, Xu Z, Wu J, Cai D. Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models. PLoS One 8: e61477, 2013.